Data sovereignty key navigating 340B's future helps healthcare leaders build integrated data systems for compliance and ...

The American Hospital Association is once again raising concerns about how a major drugmaker handles the government’s 340B ...

Rescription, Inc., a leading innovator in pharmacy benefit management, is proud to announce it has been awarded a U.S.

Many believe the federal program limits healthcare organizations and hospitals from providing discounted medications.

The American Hospital Association (AHA) expresses serious concerns with the recent announcement by Eli Lilly and Company (Lilly) to require 340B covered entities to submit claims data for all ...

The federal government has dropped its appeal of a preliminary injunction blocking implementation of the Department of Health and Human Services’ 340B Rebate Model Pilot Program.

The recent litigation concerning the government’s 340B Rebate Model Pilot Program (the Rebate Program), as further described ...

Sagebrush Health Services has filed a lawsuit against Amgen, alleging unlawful termination of discounted drug sales under the ...

The 340B Program has continued to undergo significant upheaval in 2024 that has the potential to bring about impactful changes to how the 340B Program operates moving forward. These developments have ...

Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual reports on program savings and revenues. If your health system ...

The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992, ...